青春期对患有GLUT1缺陷综合征的儿童的影响
Eric H Kossoff1, Sandra Ojeda2, Glenna Steele3
1Departments of Pediatrics and Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Pediatric neurology
|June 1, 2025
概括
青春期通常会使GLUT1缺陷综合征 (GLUT1DS) 的运动障碍恶化. 大约三分之一的经验增加了发作,偏头痛和情绪波动,基因饮食的影响各不相同.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 葡萄糖载体1型缺陷综合征 (GLUT1DS) 是一种影响儿童和运动问题的遗传疾病.
- 父母经常询问青春期对GLUT1DS症状的影响.
研究的目的:
- 调查青春期对GLUT1DS患者临床特征的影响.
- 评估青春期症状变化和治疗有效性.
主要方法:
- 一项匿名在线调查于2025年1月分发给GLUT1DS社区.
- 参与者包括父母或已完成青春期的GLUT1DS患者.
- 数据收集的重点是青春期的活动,运动障碍和其他症状.
主要成果:
- 在98名参与者中,58%的运动异常发生恶化.
- 38%的发作恶化,出现了新的症状,如偏头痛 (35%) 和情绪波动 (38%).
- 72名参与者使用了性饮食治疗;在青春期减少的症与增加的发作没有一致的相关性.
结论:
- 青春期与GLUT1DS中运动障碍的恶化有关,并可能引发发作,偏头痛和情绪波动的增加.
- 在青春期坚持素饮食可能无法防止症状恶化,尽管症水平可能下降.
相关概念视频
Glucose Transporters
24.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.3K
Inborn Errors of Metabolism
249
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
249
Signs of Puberty
645
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
645
Overview of Protein Metabolism
1.9K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.9K
Nature and Nurture
20.8K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.8K
Hypoglycemia and Glucagon
353
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
353


